News
Research Brings Hope To Neurodegenerative Disease Sufferers
The development of a neurodegenerative disease in mice is slowed down by a novel therapy, according to researchers. The ground-breaking study may provide hope for treating conditions like Alzheimer's Disease (AD), which is regarded as incurable.
Researchers at the University of...
News
NHS Should Not Employ 5 COVID Therapies, According To NICE
Five COVID-19 therapies, including Merck & Co.'s antiviral tablet for high-risk patients, have been recommended for discontinuation by Britain's agency that decides whether medications may be used in the National Health Service (NHS), citing cost-effectiveness issues.
As the pandemic moves...
Drug Research
IGBA- 2022 WHO Biosimilar Roadmap Facilitates Accessibility
According to the new whitepaper Embracing Science with Confidence: Adopting the Revised 2022 WHO Biosimilars Guideline from the International Generic and Biosimilar Medicines Association (IGBA), the framework provides a fantastic opportunity to re-evaluate how regulatory standards can better progress...
News
Abu Dhabi Airports Joins Pharma.Aero As Strategic Member
As a strategic member representing the Middle East, Abu Dhabi Airports has joined Pharma.Aero, a global member network for life science and medical technology manufacturers, certified cargo communities, and airport operators.
The partnership with Pharma.Aero builds on Abu Dhabi's development...
Drug Research
GHIT Fund Invests ¥790M On Neglected Tropical Disease Items
Two neglected tropical illnesses, lymphatic filariasis and onchocerciasis, will receive a combined investment of about 790-million-yen ($5.3 million) from the Global Health Innovative Technology (GHIT) Fund in Japan.
The parasitic worms that cause lymphatic filariasis, also known as elephantiasis, and...
Clinical Trials
A New Initiative To Assess Clinical Trials Carbon Footprint
The Clinical Trials Environmental Impact Community of Interest (CoI), a cooperative effort that aims to determine the carbon footprint of centralised and decentralised clinical trials, has been launched by The Pistoia Alliance, a non-profit organisation that promotes R&D collaboration...
Clinical Trials
Seven Pharma CEOs Team Together To Accomplish Emission Aims
Seven CEOs of pharmaceutical companies, including GSK, AstraZeneca, Merck, Roche, Novo Nordisk, Samsung Biologics, and Sanofi, have launched a collaborative effort to meet short-term emission reduction goals and hasten the implementation of net zero health systems.
The Sustainable Markets Initiative (SMI) Health...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















